Key regions: Australia, Italy, France, South Korea, Brazil
Sierra Leone, a country located in West Africa, has been experiencing a surge in demand for vaccines in recent years.
Customer preferences: Sierra Leone's population has become increasingly aware of the importance of vaccination in preventing diseases and promoting good health. The government has been actively promoting vaccination campaigns and has made efforts to increase access to vaccines in rural areas. Additionally, the country has seen a rise in the number of private healthcare providers, which has contributed to the increased demand for vaccines.
Trends in the market: The vaccines market in Sierra Leone has been growing steadily due to the government's efforts to increase access to vaccines. The country has seen an increase in the number of vaccines administered, particularly for diseases such as measles, polio, and yellow fever. The demand for vaccines has also increased due to the outbreak of diseases such as Ebola, which has raised awareness about the importance of vaccination.
Local special circumstances: Sierra Leone has faced a number of challenges in its efforts to improve access to vaccines. The country has a weak healthcare system and limited resources, which has made it difficult to implement effective vaccination campaigns. Additionally, the country has faced a number of health crises in recent years, including the Ebola outbreak, which has diverted resources away from other healthcare initiatives.
Underlying macroeconomic factors: Sierra Leone's economy has been growing in recent years, but remains one of the poorest in the world. The country faces a number of economic challenges, including high levels of poverty, unemployment, and inflation. These factors have made it difficult for the government to invest in healthcare infrastructure and to provide access to healthcare services. Additionally, the country has a high burden of disease, which has put a strain on the healthcare system and limited resources for vaccination campaigns.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
